Total Payments
$4,552
2024 Payments
$1,845
Companies
24
Transactions
123
Medicare Patients
9,404
Medicare Billing
$574,116
Payment Breakdown by Category
Food & Beverage$4,552 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,552 | 123 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | $858.60 | 10 | $0 (2024) |
| Allergan, Inc. | $570.81 | 34 | $0 (2022) |
| Glaukos Corporation | $416.14 | 3 | $0 (2024) |
| ABBVIE INC. | $415.00 | 10 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $355.78 | 11 | $0 (2024) |
| Alcon Vision LLC | $289.06 | 5 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $230.45 | 2 | $0 (2024) |
| Sight Sciences, Inc. | $190.17 | 4 | $0 (2023) |
| Amgen Inc. | $160.41 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $160.00 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,845 | 35 | BIOTISSUE HOLDINGS INC. ($858.60) |
| 2023 | $810.42 | 17 | Bausch & Lomb Americas Inc. ($239.59) |
| 2022 | $804.45 | 17 | Alcon Vision LLC ($214.38) |
| 2021 | $663.09 | 28 | Allergan, Inc. ($145.34) |
| 2020 | $264.20 | 15 | Allergan, Inc. ($222.64) |
| 2019 | $164.17 | 11 | Allergan Inc. ($100.06) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $163.76 | General |
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $7.73 | General |
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), Xelpros, BromSite | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $7.73 | General |
| 11/20/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: EYE CARE | ||||||
| 11/19/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $163.76 | General |
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: OPTOMETRY | ||||||
| 10/24/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $83.96 | General |
| 09/23/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Ophthalmology | ||||||
| 09/05/2024 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $157.47 | General |
| 09/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/22/2024 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $106.65 | General |
| 08/13/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $109.31 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: EYE CARE | ||||||
| 08/05/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $164.14 | General |
| 07/08/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $12.95 | General |
| 07/08/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $6.29 | General |
| 06/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $124.56 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,527 | 2,672 | $554,215 | $149,060 |
| 2022 | 11 | 2,383 | 2,557 | $545,670 | $142,418 |
| 2021 | 12 | 2,426 | 2,641 | $554,675 | $151,016 |
| 2020 | 9 | 2,068 | 2,258 | $313,425 | $131,621 |
Total Patients
9,404
Total Services
10,128
Medicare Billing
$574,116
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 371 | 407 | $109,890 | $35,008 | 31.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 432 | 438 | $137,970 | $33,479 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 278 | $52,820 | $17,763 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 164 | 164 | $67,240 | $17,302 | 25.7% |
| 92134 | Imaging of retina | Office | 2023 | 548 | 574 | $60,270 | $15,743 | 26.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 100 | 100 | $37,500 | $8,132 | 21.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 152 | 171 | $27,220 | $7,318 | 26.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 260 | 264 | $25,080 | $6,356 | 25.3% |
| 92250 | Photography of the retina | Office | 2023 | 210 | 218 | $29,210 | $5,686 | 19.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 31 | $3,565 | $1,291 | 36.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,970 | $883.00 | 29.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 15 | 16 | $480.00 | $101.04 | 21.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 534 | 563 | $177,345 | $44,769 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 244 | $65,880 | $20,470 | 31.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 177 | 177 | $66,375 | $16,038 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 149 | 149 | $61,090 | $15,164 | 24.8% |
| 92134 | Imaging of retina | Office | 2022 | 517 | 544 | $57,120 | $14,738 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 184 | $34,960 | $11,480 | 32.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 172 | 202 | $32,250 | $8,458 | 26.2% |
| 92250 | Photography of the retina | Office | 2022 | 225 | 227 | $26,105 | $5,669 | 21.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 211 | 223 | $21,185 | $5,121 | 24.2% |
| 92025 | Ct scan of cornea | Office | 2022 | 12 | 12 | $2,400 | $312.82 | 13.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 32 | 32 | $960.00 | $198.38 | 20.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 486 | 505 | $159,075 | $41,130 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 243 | 281 | $75,870 | $25,925 | 34.2% |
About Jaclyn Johnson
Jaclyn Johnson is a Optometrist healthcare provider based in Surprise, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2017. The National Provider Identifier (NPI) number assigned to this provider is 1700300373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jaclyn Johnson has received a total of $4,552 in payments from pharmaceutical and medical device companies, with $1,845 received in 2024. These payments were reported across 123 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,552).
As a Medicare-enrolled provider, Johnson has provided services to 9,404 Medicare beneficiaries, totaling 10,128 services with total Medicare billing of $574,116. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Surprise, AZ
- Active Since 07/26/2017
- Last Updated 11/14/2018
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1700300373
Products in Payments
- LUMIGAN (Drug) $290.33
- RESTASIS (Drug) $220.31
- VUITY (Drug) $217.68
- MIEBO (Drug) $204.06
- HYDRUS Microstent (Device) $194.34
- TEPEZZA (Biological) $160.41
- OMNI(R) SURGICAL SYSTEM (US) (Device) $156.43
- TEPEZZA (Drug) $151.90
- XIIDRA (Drug) $151.74
- Cequa (Drug) $148.53
- INFUSE (Device) $124.74
- DURYSTA (Drug) $121.93
- RESTASIS MULTIDOSE (Drug) $117.44
- KXL System (Device) $116.67
- RXSIGHT CONTACT LENS (Device) $109.31
- XDEMVY (Drug) $76.74
- rhopressa (Drug) $58.02
- Precision 1 (Device) $57.45
- TYRVAYA (Drug) $45.15
- ACTHAR (Biological) $39.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Surprise
Joseph Myers, Od, OD
Optometrist — Payments: $2,527
Optometrist $2,527
Dr. Brian Baird, O. D, O. D
Optometrist — Payments: $1,899
Optometrist $1,899
Dr. Steven Holt, Od, OD
Optometrist — Payments: $1,575
Optometrist $1,575
Chelsea Cain, O.d, O.D
Optometrist — Payments: $1,566
Optometrist $1,566
Andre Juarez, O.d, O.D
Optometrist — Payments: $966.32
Optometrist $966.32
Camille Singh, O.d, O.D
Optometrist — Payments: $813.85
Optometrist $813.85